Vasculitis Treatment Market Statistics 2020 | Global Trends, Size, Share, Analysis, Demand, Top Leaders, Comprehensive Analysis, Technology & Systems and Forecast by 2026
Global Vasculitis Treatment Market – Insights
Vasculitis, also known as angiitis, is the inflammation of the blood vessels that causes changes in the blood vessel walls. The inflammation occurs in arteries, veins, and/or capillaries and poses equal risk to men and women of any age. Inflammation of blood vessels may lead to several complications. It may block the path of blood flow thereby causing organs to dysfunction. There are a few forms of vasculitis based on the type of blood vessels affected, severity, symptoms, and duration of the disease. In the condition, the immune system does not offer defense aligned with infection. However, the major cause of the condition is not yet understood.
Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/150
Some of the factors that may cause vasculitis include, genetic makeup, blood cancers, immune system diseases (e.g. rheumatoid arthritis), infections (e.g. hepatitis B), and response to certain drugs. According to Vasculitis UK, major cause of vasculitis may be hereditary or environmental. According to National Center for Biotechnology Information (NCBI), in 2011, the therapy rituximab (Biogen Idec/Genentech, Rituxan) was the earliest and only U.S. FDA-approved therapy for the treatment of vasculitis. Such lack of approved therapies has led several governments and the manufacturers to focus on R&D of new drugs for the treatment of vasculitis. Moreover, early detection is one of the key factors for the treatment of the condition.
Global Vasculitis Treatment Market Taxonomy
On the basis of vessel size, the global vasculitis treatment market is classified into:
- Small vessel vasculitis
- Medium vessel vasculitis
- Large vessel vasculitis
On the basis of end-user, the global vasculitis treatment market is classified into:
- Medical Clinics
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/150
Global Vasculitis Treatment Market: Drivers
Major institutes and universities are focused on R&D activities related to the treatment of vasculitis, which is expected to boost growth of the global vasculitis treatment market. For instance, in August 2019, researchers from Hospital El Bierzo and Burgos University Hospital, Spain, suggested adoption of disease management based on individual patient characteristics and levels of disease severity for the treatment of vasculitis. Similarly, in August 2019, researchers from Osaka University Graduate School of Medicine, Japan found that intravenous immunoglobulin was associated with rapid improvements in disease activity and the related biomarkers in patients with active ANCA-associated vasculitis.
Increasing advancement in technology and advanced diagnosis and initiatives for the treatment of vasculitis from various governments and regulatory bodies is expected to boost growth of the global vasculitis treatment market. Moreover, increasing geriatric population is also expected to boost the market growth. For instance, according to Administration for Community Living, 46.2 million people in the U.S. were above the age of 65 in 2014. It is estimated that by 2060 there will be around 98 million people falling under this age group.
Moreover, increasing health awareness and high healthcare spending is also expected to boost growth of the global vasculitis treatment market. According to American Heart Association, although it is not established that inflammation of arteries or veins causes cardiovascular disease, it is widespread for patients with stroke and heart disease patients and is considered to be an atherogenic (deposition of fat in arteries) response. Therefore, increasing prevalence of cardiovascular diseases is also expected to boost growth of the market.
Global Vasculitis Treatment Market: Competitive Landscape
Major players in the market are focused on approval and launch of novel therapeutics intended for the treatment of various types of vasculitis. For instance, in July 2019, Pfizer Inc. announced that its RUXIENCE (rituximab-pvvr), a biosimilar to Rituxan (rituximab), intended for the treatment of adult patients with microscopic polyangiitis, received the U.S. Food and Drug Administration (FDA) approval.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/vasculitis-treatment-market-150
Major players operating in the global vasculitis treatment market include Troikaa Pharmaceuticals Ltd., Human Genome Sciences, Inc., RNL BIO Co., Ltd., GlaxoSmithKline plc, Novartis AG, Genentech, Inc., F. Hoffmann-La Roche Ltd., Anthera Pharmaceuticals‚ Inc., and Teijin Pharma Limited.
Table of Content
Global Vasculitis Treatment Market Research Report
Section 1: Global Vasculitis Treatment Industry Overview
Section 2: Global Economic Impact on Vasculitis Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Vasculitis Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Vasculitis Treatment Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire